Evidence map›Paper›PMID 25293758›Full record

ArticlemBio2014

Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.

Martin A Bewley, Michael Naughton, Julie Preston, Andrea Mitchell, Ashleigh Holmes, Helen M Marriott, Robert C Read, Timothy J Mitchell, Moira K B Whyte, David H Dockrell

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. NLRP3 inflammasome in health and disease (Review).International journal of molecular medicine · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Pyolysin ofFrontiers in immunology · 2022
    Article
  9. Review
  10. Article
  11. The Two-Component System 09 ofMicroorganisms · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Macrophage LC3-associated phagocytosis is an immune defense againstProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Martin A Bewley
Michael NaughtonDepartment of Infection and Immunity, University of Sheffield Medical School, Sheffield, United Kingdom.
Julie PrestonDepartment of Infection and Immunity, University of Sheffield Medical School, Sheffield, United Kingdom.
Andrea MitchellInstitute of Microbiology and Infection, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom.
Ashleigh HolmesJames Hutton Institute, Dundee, United Kingdom.
Helen M Marriott
Robert C ReadAcademic Unit of Clinical and Experimental Sciences and NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom.
Timothy J MitchellInstitute of Microbiology and Infection, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom.
Moira K B WhyteDepartment of Respiratory Medicine and MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
David H Dockrelld.h.dockrell@sheffield.ac.uk.
University of Sheffield · GBUniversity of Birmingham · GBJames Hutton Institute · GBNIHR Southampton Respiratory Biomedical Research Unit · GBSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity of Edinburgh · GB

Funding

Wellcome Trust 076945
6 · The paper itself

Abstract

Intracellular killing of Streptococcus pneumoniae is complemented by induction of macrophage apoptosis. Here, we show that the toxin pneumolysin (PLY) contributes both to lysosomal/phagolysosomal membrane permeabilization (LMP), an upstream event programing susceptibility to apoptosis, and to apoptosis execution via a mitochondrial pathway, through distinct mechanisms. PLY is necessary but not sufficient for the maximal induction of LMP and apoptosis. PLY's ability to induce both LMP and apoptosis is independent of its ability to form cytolytic pores and requires only the first three domains of PLY. LMP involves TLR (Toll-like receptor) but not NLRP3/ASC (nucleotide-binding oligomerization domain [Nod]-like receptor family, pyrin domain-containing protein 3/apoptosis-associated speck-like protein containing a caspase recruitment domain) signaling and is part of a PLY-dependent but phagocytosis-independent host response that includes the production of cytokines, including interleukin-1 beta (IL-1β). LMP involves progressive and selective permeability to 40-kDa but not to 250-kDa fluorescein isothiocyanate (FITC)-labeled dextran, as PLY accumulates in the cytoplasm. In contrast, the PLY-dependent execution of apoptosis requires phagocytosis and is part of a host response to intracellular bacteria that also includes NO generation. In cells challenged with PLY-deficient bacteria, reconstitution of LMP using the lysomotrophic detergent LeuLeuOMe favored cell necrosis whereas PLY reconstituted apoptosis. The results suggest that PLY contributes to macrophage activation and cytokine production but also engages LMP. Following bacterial phagocytosis, PLY triggers apoptosis and prevents macrophage necrosis as a component of a broad-based antimicrobial strategy. This illustrates how a key virulence factor can become the focus of a multilayered and coordinated innate response by macrophages, optimizing pathogen clearance and limiting inflammation. Importance: Streptococcus pneumoniae, the commonest cause of bacterial pneumonia, expresses the toxin pneumolysin, which can make holes in cell surfaces, causing tissue damage. Macrophages, resident immune cells essential for responses to bacteria in tissues, activate a program of cell suicide called apoptosis, maximizing bacterial clearance and limiting harmful inflammation. We examined pneumolysin's role in activating this response. We demonstrate that pneumolysin did not directly form holes in cells to trigger apoptosis and show that pneumolysin has two distinct roles which require only part of the molecule. Pneumolysin and other bacterial factors released by bacteria that have not been eaten by macrophages activate macrophages to release inflammatory factors but also make the cell compartment containing ingested bacteria leaky. Once inside the cell, pneumolysin ensures that the bacteria activate macrophage apoptosis, rather than necrosis, enhancing bacterial killing and limiting inflammation. This dual response to pneumolysin is critical for an effective immune response to S. pneumoniae.

Indexed as

ApoptosisAnimalsBacterial ProteinsCells, CulturedHumansIntracellular MembranesLysosomesMacrophagesMicePermeabilityStreptococcus pneumoniaeStreptolysinsBacterial ProteinsplY protein, Streptococcus pneumoniaeStreptolysins

Identifiers

PMID25293758
PMCPMC4196231
OpenAlexW2101813663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.